NEW YORK (GenomeWeb) – Researchers this week shared early data from the first 100 patients in the ongoing TRACERx (Tracking Cancer Evolution through Therapy) lung cancer study, illustrating how the effort is illuminating the clonal evolution of the disease in new ways, with implications for possible new targeted and immunotherapy.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.